fig2
![Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis](https://image.oaes.cc/410b6154-8707-46b7-abf3-1fe809ab2ce0/mrr3005.fig.2.jpg)
Figure 2. Schematic representation of the inflammatory pathway from the gut to adipose tissue and the resulting consequences on human health. LPS: Lipopolysaccharide; LBP: lipopolysaccharide binding protein; CD14: cluster of differentiation 14; NF-κB: nuclear factor kappa B.